Loss of IRF8 function increases secretion of both G-CSF and GM-CSF, ligands that upon high affinity cognate receptor activation on myeloid progenitor cells promote myeloid-mediated T cell suppression, in alignment with the inverse relationship between IRF8 levels and these cells observed in patients with BC and coinciding with poorer prognosis [48]. Here, CSF2 is linked to breast cancer.